Kidney size and glomerular filtration rate (GFR) often increase with the onset of diabetes,
and elevated GFR is a risk factor for the development of diabetic kidney disease …

Diabetic kidney disease (DKD) is the primary cause of chronic kidney disease around the
globe and is one of the main complications in patients with type 1 and 2 diabetes. The …

The kidneys filter large amounts of glucose. To prevent the loss of this valuable fuel, the
tubular system of the kidney, particularly the proximal tubule, has been programmed to …

The endocannabinoid system (ECS) is one of the most crucial systems in the human
organism, exhibiting multi-purpose regulatory character. It is engaged in a vast array of …

Diabetic kidney disease (DKD) is the leading cause of end stage renal disease (ESRD) in
the USA. The pathogenesis of DKD is multifactorial and involves activation of multiple …

Endocannabinoids acting via CB 1 receptors (CB 1 R) play a critical role in regulating
energy homeostasis, which was the rationale for the pharmaceutical development of CB 1 R …

Diabetic nephropathy (DN) is a common pathological feature in patients with diabetes and
the leading cause of end-stage renal disease. Although several pharmacological agents …

The endocannabinoid (eCB) system is widely expressed in many central and peripheral
tissues, and is involved in a plethora of physiological processes. Among these, activity of the …

Diabetic nephropathy (DN) has become a leading cause of end-stage renal failure
worldwide. The goal of the current study was to examine the protective effects of chitosan …

Current Opinion in Nephrology and Hypertension Log in or Register Subscribe to journalSubscribe
Get new issue alertsGet alerts Secondary Logo Journal Logo Advanced Search Toggle …